Natera (NTRA)
(Real Time Quote from BATS)
$176.24 USD
+1.23 (0.70%)
Updated Sep 17, 2025 09:46 AM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NTRA 176.24 +1.23(0.70%)
Will NTRA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NTRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NTRA
Natera Shares Rise on the Launch of AI Platform for Precision Oncology
Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics
NTRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates
Medpace (MEDP) Q2 Earnings and Revenues Surpass Estimates
Other News for NTRA
Is NTRA poised for gains? MACD Bullish Signal Line Cross shows up after gaining 1.66%
1,2,3 Pullback Bullish appears for NTRA after 2.17% move
Piper Sandler Reaffirms Their Buy Rating on Natera (NTRA)
If You Invested $100 In Natera Stock 5 Years Ago, You Would Have This Much Today
The technical outlook for NTRA is unchanged after it falls 3.05% on September 12